Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 6
2005 6
2006 8
2007 11
2008 14
2009 16
2010 22
2011 23
2012 33
2013 20
2014 18
2015 24
2016 28
2017 26
2018 38
2019 29
2020 29
2021 32
2022 33
2023 23
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

399 results

Results by year

Filters applied: . Clear all
Page 1
A step forward in the journey towards hookworm vaccines.
Keiser J, Bouchery T. Keiser J, et al. Lancet Infect Dis. 2024 Mar 18:S1473-3099(24)00145-2. doi: 10.1016/S1473-3099(24)00145-2. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38513685 No abstract available.
Structure-activity relationship and target investigation of 2-aryl quinolines with nematocidal activity.
Shanley HT, Taki AC, Nguyen N, Wang T, Byrne JJ, Ang CS, Leeming MG, Nie S, Williamson N, Zheng Y, Young ND, Korhonen PK, Hofmann A, Chang BCH, Wells TNC, Häberli C, Keiser J, Jabbar A, Sleebs BE, Gasser RB. Shanley HT, et al. Among authors: keiser j. Int J Parasitol Drugs Drug Resist. 2024 Apr;24:100522. doi: 10.1016/j.ijpddr.2024.100522. Epub 2024 Jan 23. Int J Parasitol Drugs Drug Resist. 2024. PMID: 38295619 Free PMC article.
Strongyloidiasis.
Gordon CA, Utzinger J, Muhi S, Becker SL, Keiser J, Khieu V, Gray DJ. Gordon CA, et al. Among authors: keiser j. Nat Rev Dis Primers. 2024 Jan 25;10(1):6. doi: 10.1038/s41572-023-00490-x. Nat Rev Dis Primers. 2024. PMID: 38272922 Review.
Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, non-inferiority, phase 2b/3 trial.
Sprecher VP, Hofmann D, Savathdy V, Xayavong P, Norkhankhame C, Huy R, Khieu V, Sayasone S, Hattendorf J, Keiser J. Sprecher VP, et al. Among authors: keiser j. Lancet Infect Dis. 2024 Feb;24(2):196-205. doi: 10.1016/S1473-3099(23)00507-8. Epub 2023 Nov 7. Lancet Infect Dis. 2024. PMID: 37949090 Clinical Trial.
399 results